ARS PHARMACEUTICALS INC (SPRY)
US82835W1080 - Common Stock
ChartMill assigns a Buy % Consensus number of 88% to SPRY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 29.58. This target is 160.39% above the current price.
SPRY was analyzed by 10 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about SPRY.
In the previous month the buy percentage consensus was at a similar level.
SPRY was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-14 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-01-13 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-10-08 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-20 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-09-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-20 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-08-13 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2024-07-25 | Raymond James | Initiate | Outperform |
| 2024-03-11 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-05 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2023-11-13 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-09-21 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-09-20 | William Blair | Downgrade | Outperform -> Market Perform |
| 2023-08-14 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-06-21 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-05-18 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-05-12 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-05-10 | Wedbush | Reiterate | Outperform |
| 2023-01-31 | Wedbush | Initiate | Outperform |
| 2023-01-04 | William Blair | Initiate | Outperform |
| 2022-12-13 | SVB Leerink | Initiate | Outperform |